ERCC1 and colorectal cancer: The results showed that the overexpression of ERCC1 did not affect the overall survival rate and disease-free survival rate in patients with rectal cancer; however, our previous study found that the overexpression of ERCC1 in colorectal cancer patients undergoing concurrent chemoradiotherapy has a poor prognosis [28].